Outstanding Contributions to the Canadian Cancer Research Community
Today, the CCRA recognizes six leaders in Canadian cancer research, including two inaugural Indigenous awards recipients. The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on cancer research and the cancer research community.
This year’s inaugural Award for Excellence in a First Nations, Inuit and Métis Community Project is Sitansisk Wolastoqey (St. Mary’s First Nation), represented by Sherry Parsons, for the Radiant Spirits: Indigenous Mammogram and Breast Health Initiative. The five individual recipients of the 2025 Awards are, in alphabetical order: Dr. Christine M. Friedenreich, recipient of the Philip E. Branton Exceptional Leadership in Cancer Research award, Dr. Nada Jabado, recipient of the Outstanding Achievements in Cancer Research award, Dr. Lana Ray, inaugural recipient of the Excellence in First Nations, Inuit and Métis Cancer Research award, Dr. Sevtap Savas, recipient of the Exceptional Leadership in Patient Involvement in Cancer Research award and Dr. Barbara C. Vanderhyden, recipient of the Distinguished Service to Cancer Research award.
An awards presentation will be held at the Canadian Cancer Research Conference in Calgary on November 2. For more information, please go to the Awards page and read today’s press release.
Story Visualizations Released
As companions to our 2016 special topic reports, CCRA has released interactive 'story visualizations' using Tableau software. Story visualizations are dashboards that are linked sequentially. They walk users through a series of analyses, each with greater detail, and allowing users more opportunity to ‘interact’ with ... Read More »
As companions to our 2016 special topic reports, CCRA has released interactive 'story visualizations' using Tableau software. Story visualizations are dashboards that are linked sequentially. They walk users through a series of analyses, each with greater detail, and allowing users more opportunity to ‘interact’ with ... Read More »
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »